Skip to content

Accuracy and effectiveness of posterior gleno humeral joint injection.

Accuracy and effectiveness of posterior gleno humeral joint injection. - Accuracy and effectiveness of gleno humeral joint injection.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39599
Enrollment
30
Registered
2013-09-02
Start date
2014-04-07
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Capsulitis adhesiva Frozen shoulder

Interventions

None listed

Sponsors

Rijnland Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Intra-articular corticoid injection is indicated with capsulitis adhesiva.

Exclusion criteria

Exclusion criteria: -Known allergic reaction on Depomedrol, Lidocaine or contrast. -Clinical signs of full thickness rotatorcuff rupture. -Clinical signs of infection. -Within 6 weeks after rotatorcuff repair operation. -Pregnancy.

Design outcomes

Primary

MeasureTime frame
Questionaires: - VAS (Visual Analoge Scale) Pain - DASH (Disabilities of the Arm, Schoulder and Hand) - SST (Simple Shoulder Test) - Constant Murley Score Injection corticosteroids/lidocaine/contrast: An X-ray is made to see if the injection was placed intraarticular.

Secondary

MeasureTime frame
nvt

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)